{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:55Z","timestamp":1792143895255,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":11,"publisher":"Springer US","isbn-type":[{"value":"9781071655863","type":"print"},{"value":"9781071655870","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5587-0_19","type":"book-chapter","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:54Z","timestamp":1792140894000},"page":"307-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor Growth Analysis of Ewing Sarcoma Cell Lines Using Subcutaneous Xenografts in Mice"],"prefix":"10.1007","author":[{"given":"Florencia","family":"Cidre-Aranaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.4161\/cbt.213","volume":"2","author":"RS Kerbel","year":"2003","unstructured":"Kerbel RS (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived\u2014but they can be improved. Cancer Biol Ther 2:S134\u2013139","journal-title":"Cancer Biol Ther"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ejca.2003.11.028","volume":"40","author":"LR Kelland","year":"2004","unstructured":"Kelland LR (2004) Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40:827\u2013836","journal-title":"Eur J Cancer"},{"issue":"1","key":"19_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<156::AID-IJC24>3.0.CO;2-D","volume":"73","author":"G Vassal","year":"1997","unstructured":"Vassal G, Boland I, Santos A et al. (1997) Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice. Int J Cancer 73(1):156\u201363","journal-title":"Int J Cancer"},{"issue":"1","key":"19_CR4","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1038\/s41467-025-60519-5","volume":"16","author":"R Imle","year":"2025","unstructured":"Imle R, Bl\u00f6sel D, Kommoss FKF et al. (2025) Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomas. Nat Commun 16(1):5283","journal-title":"Nat Commun"},{"key":"19_CR5","doi-asserted-by":"crossref","unstructured":"Nielsen SW (1976) Comparative pathology of bone tumors in animals, with particular emphasis on the dog. In: Grundmann E (eds) Malignant bone tumors. Recent Results in Cancer Research \/ Fortschritte der Krebsforschung \/ Progr\u00e8s dans les recherches sur le cancer, vol 54. Springer, Berlin, Heidelberg, pp 3\u201316","DOI":"10.1007\/978-3-642-80997-2_2"},{"key":"19_CR6","first-page":"833","volume":"39","author":"FE Sharkey","year":"1979","unstructured":"Sharkey FE, Fogh J (1979) Incidence and pathological features of spontaneous tumors in athymic nude mice. Cancer Res 39:833\u2013839","journal-title":"Cancer Res"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"34141","DOI":"10.18632\/oncotarget.9388","volume":"8","author":"TZ Minas","year":"2017","unstructured":"Minas TZ, Surdez D, Javaheri T et al. (2017) Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model. Oncotarget 8:34141\u201334163","journal-title":"Oncotarget"},{"key":"19_CR8","first-page":"887","volume":"4","author":"RM Mohammad","year":"1998","unstructured":"Mohammad RM, Al-Katib A, Pettit GR et al. (1998) An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies. Clin Cancer Res 4:887\u2013894","journal-title":"Clin Cancer Res"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.celrep.2014.09.028","volume":"9","author":"E Stewart","year":"2014","unstructured":"Stewart E, Goshorn R, Bradley C et al. (2014) Targeting the DNA repair pathway in Ewing sarcoma. Cell Rep 9:829\u2013841","journal-title":"Cell Rep"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature23647","volume":"549","author":"E Stewart","year":"2017","unstructured":"Stewart E, Federico SM, Chen X et al. (2017) Orthotopic patient-derived xenografts of paediatric solid tumours. Nature 549:96\u2013100","journal-title":"Nature"},{"issue":"1","key":"19_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01470-z","volume":"21","author":"F Cidre-Aranaz","year":"2022","unstructured":"Cidre-Aranaz F, Li J, H\u00f6lting TLB et al. (2022) Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma. Mol Cancer 21(1):1","journal-title":"Mol Cancer"}],"container-title":["Methods in Molecular Biology","Ewing Sarcoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5587-0_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:55Z","timestamp":1792140895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-1-0716-5587-0_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"ISBN":["9781071655863","9781071655870"],"references-count":11,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5587-0_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"16 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}